Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 2.580
+0.030 (1.18%)
Mar 6, 2026, 5:03 PM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 31.59 million as of March 6, 2026. Its market cap has decreased by -38.84% in one year.
Market Cap
31.59M
Enterprise Value
46.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.58
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has increased from 26.85M to 31.59M, an increase of 17.67%. That is a compound annual growth rate of 2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 31.22M | 7.38% |
| Dec 30, 2025 | 29.08M | -54.90% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 601.12M |
| Captor Therapeutics Spolka Akcyjna | 463.31M |
| Bioceltix | 388.54M |
| BIOTON | 358.91M |
| Synthaverse | 254.77M |
| Molecure | 150.40M |
| Mabion | 130.91M |
| Poltreg | 114.72M |